Drugs / Lung stem cells
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02745184 | Mar 2017 → Aug 2020 | idiopathic pulmonary fibrosis | Shanghai East Hospital | Completed | No outcome recorded |
| Phase 1/2 | NCT02796781 | Oct 2016 → Aug 2020 | interstitial lung disease | Shanghai East Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lung stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02745184 ↗ |
| Known as | LSCs | “clinical grade lung stem cells (LSCs)” NCT02745184 ↗ |
| Route | Other | “injected via fiberoptic bronchoscopy” NCT02745184 ↗ |